Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-09

Clinical Trial Update: Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for patients with Type 2 diabetes mellitus who have insufficient glycemic control on metformin alone or metformin with a sulfony…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfonylurea (sulfonylurea)
  • metformin (metformin)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN